Re: Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder: Results of a European Organization for the Research and Treatment of Cancer-Genito-Urinary Group Phase III Trial (30906)

Journal of Urology

Volume 3 - Number

Article Type: ---- Unspecified ----
Abstract:
Keyword: